Simplify Logo

Full-Time

Director – Business Development and Strategy

Clinical

Confirmed live in the last 24 hours

23andMe

23andMe

501-1,000 employees

Direct-to-consumer DNA testing services

Consulting
Hardware
Biotechnology
Healthcare

Compensation Overview

$220.8k - $331.2kAnnually

Senior, Expert

Sunnyvale, CA, USA

Category
Business Development
Business & Strategy
Requirements
  • Bachelor’s, preferably in the life sciences. MD/PhD or MS+MBA in a relevant field preferred
  • A minimum of 10 years of experience in business development. 5+ years in a senior strategic role
  • Strong track record of sourcing, negotiating, and closing partnerships with positive results
  • Extensive network of healthcare industry contacts
  • Strategic thinking with outstanding business instincts, can help chart the course and can translate plans into value-creating results for the company
  • Ability to apply critical, strategic, and scientific/technical thinking to unstructured situations to make sound business judgments
  • Demonstrated ability to lead projects and teams with attention to detail, and to influence without authority
  • Resourceful self-starter with strong alignment with 23andMe’s core values
  • Ability to work effectively in a dynamic, entrepreneurial environment and a bias towards 'win-win' collaboration at all levels
Responsibilities
  • The Director, Business Development and Strategy, Clinical will serve as an internal and external face of the company and will bring a strong track record of innovation, business development deals and value creation, combined with a network of relevant business connections within the healthcare space.
  • This individual will be responsible for identifying, pursuing and closing deals with healthcare systems, employers, payors and healthtech companies.

23andMe offers direct-to-consumer DNA testing that provides individuals with insights into their ancestry, genetic traits, and potential health risks. Customers purchase a DNA testing kit, send in a saliva sample, and receive personalized genetic reports based on the analysis of their DNA. This service appeals to a wide range of people, from those curious about their family history to those wanting to understand their genetic health predispositions. Unlike many competitors, 23andMe not only sells DNA kits but also offers subscription services for ongoing updates and insights, creating a recurring revenue model. Additionally, the company utilizes its large genetic database for research, partnering with institutions and pharmaceutical companies to advance genetic studies and potentially discover new treatments. The goal of 23andMe is to empower individuals with knowledge about their genetics while contributing to broader scientific research.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Sunnyvale, California

Founded

2006

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-5%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of new features like the Biological Age and Bipolar Disorder reports demonstrates 23andMe's commitment to expanding its health insights offerings.
  • Partnerships with companies like Nightingale Health and Innate Pharma highlight 23andMe's role in advancing personalized medicine and cancer treatment.
  • The company's large-scale studies, such as the LRRK2 variant research, position it as a leader in genetic research and contribute to significant scientific discoveries.

What critics are saying

  • Security breaches, like the one affecting 7 million users, pose significant risks to customer trust and data integrity.
  • The potential move to go private again could create uncertainty and instability for employees and investors.

What makes 23andMe unique

  • 23andMe's direct-to-consumer model democratizes access to genetic insights, unlike traditional genetic testing services that require medical intermediaries.
  • The company's extensive genetic database, leveraged for research partnerships, provides a unique revenue stream and accelerates genetic research.
  • 23andMe's integration of genetic and blood biomarker data through partnerships like Nightingale Health offers a more comprehensive health assessment than competitors.

Benefits

Comprehensive health, vision, & dental plans

Family planning, support, & leave for parents

Mental healthcare

Student loan assistance

Volunteer time off

Dog friendly office